Medicamen Organ. — 360° view

Medicamen Organ, a company in the Pharmaceuticals industry, reported revenue of ₹7.00 crore and a net loss of ₹4.00 crore for the September 2026 quarter.

Medicamen Organ. (NSE: MEDIORG-SM) closed at ₹22.20 on 20 Nov 2026, down 15.4% over the past year. Its market capitalisation is ₹33 crore.

Share price
₹22.20 (20 Nov 2026)
Market cap
₹33 Cr (20 Nov 2026)
Revenue
₹7 Cr (September 2026 quarter)
Net profit
₹-4 Cr (September 2026 quarter)
ROCE
-10.4% (FY26)
ROE
-13.8% (FY26)
Book value
₹24.8 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹32.00 / ₹19.10 (20 Nov 2026)
1-year return
-15.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: MEDIORG-SM

Incorporated in 1995, Medicamen Organics Ltd develops, manufactures, and distributes a broad range of pharmaceutical dosages including generic dosage

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.